|
Variables
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
Average survival time (SE)
|
95%CI
|
P-value
|
Exp (B)
|
95.0%CI
|
P-value
|
|---|
|
p-S6
|
|
High expression
|
44.561 (3.050)
|
38.583-50.540
|
0.013*
|
1.549
|
1.105-2.173
|
0.011*
|
|
Low expression
|
67.500 (5.336)
|
57.041-77.958
| | | | |
|
Clinical stages
|
|
Stage I-II
|
68.200 (4.195)
|
59.977-76.423
|
0.000*
|
1.980
|
1.356-2.893
|
0.000*
|
|
Stage III
|
47.862 (3.834)
|
40.347-55.378
| | | | |
|
LN status
|
|
LNM
|
44.969 (3.201)
|
38.695-51.243
|
0.000*
|
1.609
|
1.098-2.360
|
0.015*
|
|
No LNM
|
74.932 (5.919)
|
63.330-86.533
| | | | |
|
Histological type
|
|
SCC
|
63.464 (5.825)
|
52.046-74.882
|
0.240
|
1.137
|
0.806-1.603
|
0.464
|
|
ADC
|
50.588 (3.367)
|
43.988-57.188
| | | | |
|
Pathological grade
|
|
Well/moderated
|
58.662 (3.509)
|
51.784-65.541
|
0.003*
|
1.517
|
1.094-2.104
|
0.013*
|
|
Poor
|
54.226 (4.164)
|
46.066-62.387
| | | | |
|
Age
|
|
≤ 50
|
45.395 (3.633)
|
38.274-52.515
|
0.454
|
1.014
|
0.718-1.430
|
0.939
|
|
>50
|
61.199 (4.064)
|
53.234-69.165
| | | | |
|
Gender
|
|
Female
|
54.566 (4.467)
|
45.810-63.321
|
0.210
|
0.718
|
0.484-1.064
|
0.099
|
|
Male
|
57.363 (3.886)
|
49.747-64.978
| | | | |
- Abbreviations: CI Confidence interval, Exp(B) Odds ratio, SE Standard error, LNM Lymph node metastasis;
- * P < 0.05
